PetMed Express Inc (PETS)

Add to Watchlists
Create an Alert
Quickflows
33.11 +0.20  +0.61% NASDAQ Apr 9, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All PETS News

News

View All Events

Events

Date Type Description
05/04/2020 08:00 EDT Earnings Calls Q4 2020 Earnings Call
05/04/2020 00:00 Earnings Results Q4 2020 Earnings Results
05/14/2020 None Dividends 0.28 Normal, declared May 04, 2020 and paid May 22, 2020
07/20/2020 08:30 EDT Earnings Calls Q1 2021 Earnings Call
07/20/2020 08:00 EDT Earnings Results Q1 2021 Earnings Results
07/30/2020 None Dividends 0.28 Normal, declared July 20, 2020 and paid August 07, 2020
07/31/2020 13:00 EDT Agm 2020 Annual General Meeting
10/26/2020 08:00 EDT Earnings Results Q2 2021 Earnings Results
10/26/2020 08:30 EDT Earnings Calls Q2 2021 Earnings Call
11/06/2020 None Dividends 0.28 Normal, declared October 26, 2020 and paid November 20, 2020
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 311.82M
Total Expenses (TTM) 274.11M
Net Income (TTM) 30.79M

Balance Sheet View Statement

Total Assets (Quarterly) 167.37M
Total Liabilities (Quarterly) 0.003M
Shareholders Equity (Quarterly) 139.13M

Cash Flow Statement View Statement

Cash from Operations (TTM) 38.89M
Cash from Investing (TTM) -2.332M
Cash from Financing (TTM) -22.43M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.1800petmeds.com
  • Investor Relations URL: http://investor-relations.petmeds.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Pharmaceutical Retailers
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: May. 04, 2021
  • Last Earnings Release: Jan. 19, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jan. 29, 2021
  • Description: PetMed Express Inc along with its and subsidiaries is a leading nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 33.11
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
F000014NTM ST Fundamental Equity Contrarians 1 F RE 4.21%
F0000163PZ ST Fundamental Equity Contrarians 4 F RE 3.54%
ONLN ProShares Online Retail ETF 3.15%
TDV ProShares S&PTech Div Arstcrts ETF 2.97%
CLIX ProShares Long Online/Short Stores ETF 2.91%
NSDVX North Star Dividend I 2.08%
IBUY Amplify Online Retail ETF 1.99%
SMDV ProShares Russell 2000 Dividend Growers 1.37%
PAWZ ProShares Pet Care ETF 1.25%
HSGFX Hussman Strategic Growth 1.02%
HSAFX Hussman Strategic Allocation 0.60%

Comparables

Edit
HSKA Heska Corp
ANIX Anixa Biosciences Inc
CPSI Computer Programs and Systems Inc
MDRX Allscripts Healthcare Solutions Inc
STRM Streamline Health Solutions Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.